L’Oreal Appoints Research, Innovation And Tech Head; Shiseido’s First Female Regional CEO; Beauty Exec News
Beginning in February 2021, Barbara Lavernos, chief technologies and operations officer at L’Oreal, will be president of research, innovation and technologies, a role that CEO Jean-Paul Agon says is crucial to the company’s BeautyTech future. More beauty industry people news.
You may also be interested in...
Gilead's remdesivir is first drug fully approved by FDA to treat COVID-19. Roche and Atea team up on an investigational direct acting antiviral while Moderna reaches the 30,000-patient enrollment target for its Phase III COVE study of the company's investigational mRNA vaccine.
From efficacy endpoints to patient warehousing, US FDA advisors weigh in on vaccine development and regulatory review.
Several years ago, heart device giant Edwards Lifesciences realized it needed a new CAPA framework that shifts corrective and preventive action from a one-size-fits-all method to a more nuanced approach. See what Dan Buehner, director of quality engineering at Edwards Lifesciences, said about it here.